These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7349092

  • 1. Effects of combined treatment of L1210 leukemia with adriamycin and pustulan.
    Fiszer-Maliszewska L, Mordarski M.
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):703-10. PubMed ID: 7349092
    [Abstract] [Full Text] [Related]

  • 2. Morphological changes in organs of mice induced by the combination of adriamycin and pustulan.
    Fiszer-Maliszewska L, Mordarski M, Madej JA, Kotz J.
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):365-72. PubMed ID: 6651486
    [Abstract] [Full Text] [Related]

  • 3. Combined therapy of mice bearing L1210 leukemia with adriamycin and mycobacteria.
    Fiszer L, Mordarski M.
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):873-9. PubMed ID: 749836
    [Abstract] [Full Text] [Related]

  • 4. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL, Roberts D.
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The use of liposomes as carriers of therapeutic agents.
    Mayhew E, Rustum YM.
    Prog Clin Biol Res; 1985 Mar; 172B():301-10. PubMed ID: 3887426
    [Abstract] [Full Text] [Related]

  • 8. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T.
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [Abstract] [Full Text] [Related]

  • 9. Effect of vitamin E on toxicity and antitumor activity of adriamycin in mice.
    Tanigawa N, Katoh H, Kan N, Mizuno Y, Tanimura H, Satomura K, Hikasa Y.
    Jpn J Cancer Res; 1986 Dec; 77(12):1249-55. PubMed ID: 3102429
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
    Marks TA, Venditti JM.
    Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
    [Abstract] [Full Text] [Related]

  • 11. Circadian bioperiodic response of mice bearing advanced L1210 leukemia to combination therapy with adriamycin and cyclophosphamide.
    Scheving LE, Burns ER, Pauly JE, Halberg F.
    Cancer Res; 1980 May; 40(5):1511-5. PubMed ID: 7370988
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Doxorubicin and ricin, a strongly synergistic combination in mouse leukemia.
    Fodstad O, Pihl A.
    Cancer Treat Rep; 1980 May; 64(12):1375-8. PubMed ID: 7471125
    [Abstract] [Full Text] [Related]

  • 20. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
    Moran RE, Straus MJ.
    Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.